Skip to main content

Table 2 Clinical Characteristics

From: Development of the neurotrophic keratopathy questionnaire: qualitative research

CharacteristicTotal(N = 14)
Date of Diagnosis (months)
 Mean (SD)28.2 (17.4)
 Median [Range]28.6 (3–80)
Current Mackie Classification, n (%)
 Stage I2 (14.3%)
 Stage II3 (21.4%)
 Stage III9 (64.3%)
Health Conditions, n (%)a
 None2 (14.3%)
 Anxiety2 (14.3%)
 Arthritis4 (28.6%)
 Cancer3 (21.4%)
 COPD2 (14.3%)
 Depression2 (14.3%)
 Diabetes1 (7.1%)
 Hypertension5 (35.7%)
 Multiple sclerosis1 (7.1%)
 Psychosis1 (7.1%)
 Otherb6 (42.9%)
  1. aNot mutually exclusive
  2. bOther health conditions include: “asthma, stroke” (n = 1), “IBS, GERD, sleep problems” (n = 1), “LDL” (n = 1), “sarcoidosis” (n = 1), “hyperthyroidism, mitral valve regurgitation” (n = 1), and “mal de debarquement syndrome, CKD stage III, vertigo” (n = 1)
  3. Abbreviations: CKD Chronic kidney disease, COPD Chronic obstructive pulmonary disease, GERD Gastroesophageal reflux disease, IBS Inflammatory bowel syndrome, LDL Low-density lipoprotein, SD Standard deviation